Evaluation of Growth Hormone Treatment in adolescence: Effect on body composition, bones, glucose and lipids in patients who were treated with this hormone

Phase 2

• Conditions: Osteoporosis; C26.404

• Registration Number: RBR-29sg4xg
• Lead Sponsor: niversidade de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-12-30
• Study Completion: 2022-12-31
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

both gender; 14 to 20 years of age; growth speed less than 2 cm/year; bone age equal to or greater than 15 years in girls and 16 years in boys; somatropin use for 3 consecutive years

Exclusion Criteria

chronic renal failure; type 1 diabetes mellitus; osteopathies; Prader Willi syndrome; chronic use of corticosteroids

Study & Design

• Study Type: Intervention
• Study Design: Not specified